Stay updated on Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study details and associated documents with a minimal error view; a Home link is shown on the error page.
    Difference
    18%
    Check dated 2026-09-24T20:54:56.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0, indicating a new release of the page's underlying software. This deployment reflects behind-the-scenes changes rather than edits to the study details.
    Difference
    0.0%
    Check dated 2026-09-17T22:07:42.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Tel Litwinsky, Israel, 52621 was added to the study locations, and Qiryat Krinitzi, Israel, 52621 was removed. This update changes the set of sites where participants may enroll and receive trial-related procedures.
    Difference
    0.1%
    Check dated 2026-09-10T21:57:50.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The study locations were updated by adding Qiryat Krinitzi, Israel, 52621 and removing Tel Litwinsky, Israel, 52621, thereby altering the geographic options for potential participants.
    Difference
    0.1%
    Check dated 2026-09-03T19:16:57.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added a line in the Study IDs section: 2015 ( U.S. NIH Grant/Contract ). This reflects NIH funding associated with the study record.
    Difference
    0.0%
    Check dated 2026-08-27T18:29:55.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    No additions or deletions were reported for this page, so there is no textual change to summarize.
    Difference
    0.0%
    Check dated 2026-08-13T21:01:16.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.